This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mukhopadhyay, D.
Right arrow Articles by Sukhatme, V. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mukhopadhyay, D.
Right arrow Articles by Sukhatme, V. P.

 Previous Article  |  Next Article 

Mol. Cell. Biol., Sep 1997, 5629-5639, Vol 17, No. 9
Copyright © 1997, American Society for Microbiology

The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity

D Mukhopadhyay, B Knebelmann, HT Cohen, S Ananth and VP Sukhatme
Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA.

The von Hippel-Lindau tumor suppressor gene (VHL) has a critical role in the pathogenesis of clear-cell renal cell carcinoma (RCC), as VHL mutations have been found in both von Hippel-Lindau disease-associated and sporadic RCCs. Recent studies suggest that vascular endothelial growth factor (VEGF) mRNA is upregulated in RCC- and von Hippel-Lindau disease-associated tumors. We have therefore assessed the effect of the VHL gene product on VEGF expression. VEGF promoter-luciferase constructs were transiently cotransfected with a wild-type VHL (wt-VHL) vector in several cell lines, including 293 embryonic kidney and RCC cell lines. wt-VHL protein inhibited VEGF promoter activity in a dose- dependent manner up to 5- to 10-fold. Deletion analysis defined a 144- bp region of the VEGF promoter necessary for VHL repression. This VHL- responsive element is GC rich and specifically binds the transcription factor Sp1 in crude nuclear extracts. In Drosophila cells, cotransfected VHL represses Sp1-mediated activation but not basal activity of the VEGF promoter. We next demonstrated in coimmunoprecipitates that VHL and Sp1 were part of the same complex and, by using a glutathione-S-transferase-VHL fusion protein and purified Sp1, that VHL and Sp1 directly interact. Furthermore, endogenous VEGF mRNA levels were suppressed in permanent RCC cell lines expressing wt-VHL, and nuclear run-on studies indicated that VHL regulation of VEGF occurs at least partly at the transcriptional level. These observations support a new mechanism for VHL-mediated transcriptional repression via a direct inhibitory action on Sp1 and suggest that loss of Sp1 inhibition may be important in the pathogenesis of von Hippel-Lindau disease and RCC.


This article has been cited by other articles:

  • Sinha, S., Dutta, S., Datta, K., Ghosh, A. K., Mukhopadhyay, D. (2009). Von Hippel-Lindau Gene Product Modulates TIS11B Expression in Renal Cell Carcinoma: IMPACT ON VASCULAR ENDOTHELIAL GROWTH FACTOR EXPRESSION IN HYPOXIA. J. Biol. Chem. 284: 32610-32618 [Abstract] [Full Text]  
  • Tan, S. H., Pal, M., Tan, M. J., Wong, M. H. L., Tam, F. U., Teo, J. W. T., Chong, H. C., Tan, C. K., Goh, Y. Y., Tang, M. B. Y., Cheung, P. C. F., Tan, N. S. (2009). Regulation of Cell Proliferation and Migration by TAK1 via Transcriptional Control of von Hippel-Lindau Tumor Suppressor. J. Biol. Chem. 284: 18047-18058 [Abstract] [Full Text]  
  • Chong, H. C., Tan, M. J., Philippe, V., Tan, S. H., Tan, C. K., Ku, C. W., Goh, Y. Y., Wahli, W., Michalik, L., Tan, N. S. (2009). Regulation of epithelial-mesenchymal IL-1 signaling by PPAR{beta}/{delta} is essential for skin homeostasis and wound healing. JCB 184: 817-831 [Abstract] [Full Text]  
  • Jimenez, C., Cabanillas, M. E., Santarpia, L., Jonasch, E., Kyle, K. L., Lano, E. A., Matin, S. F., Nunez, R. F., Perrier, N. D., Phan, A., Rich, T. A., Shah, B., Williams, M. D., Waguespack, S. G. (2009). Use of the Tyrosine Kinase Inhibitor Sunitinib in a Patient with von Hippel-Lindau Disease: Targeting Angiogenic Factors in Pheochromocytoma and Other von Hippel-Lindau Disease-Related Tumors. J. Clin. Endocrinol. Metab. 94: 386-391 [Abstract] [Full Text]  
  • Birk, D. M., Barbato, J., Mureebe, L., Chaer, R. A. (2009). Basic Science Review: Current Insights on the Biology and Clinical Aspects of VEGF Regulation. VASC ENDOVASCULAR SURG 42: 517-530 [Abstract]  
  • Eltzschig, H. K., Kohler, D., Eckle, T., Kong, T., Robson, S. C., Colgan, S. P. (2009). Central role of Sp1-regulated CD39 in hypoxia/ischemia protection. Blood 113: 224-232 [Abstract] [Full Text]  
  • Wan, H., Luo, F., Wert, S. E., Zhang, L., Xu, Y., Ikegami, M., Maeda, Y., Bell, S. M., Whitsett, J. A. (2008). Kruppel-like factor 5 is required for perinatal lung morphogenesis and function. Development 135: 2563-2572 [Abstract] [Full Text]  
  • Basu, A., Contreras, A. G., Datta, D., Flynn, E., Zeng, L., Cohen, H. T., Briscoe, D. M., Pal, S. (2008). Overexpression of Vascular Endothelial Growth Factor and the Development of Post-Transplantation Cancer. Cancer Res. 68: 5689-5698 [Abstract] [Full Text]  
  • Maeda, Y., Suzuki, T., Pan, X., Chen, G., Pan, S., Bartman, T., Whitsett, J. A. (2008). CUL2 Is Required for the Activity of Hypoxia-inducible Factor and Vasculogenesis. J. Biol. Chem. 283: 16084-16092 [Abstract] [Full Text]  
  • Ellen, T. P., Ke, Q., Zhang, P., Costa, M. (2008). NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states. Carcinogenesis 29: 2-8 [Abstract] [Full Text]  
  • Harper, J., Yan, L., Loureiro, R. M., Wu, I., Fang, J., D'Amore, P. A., Moses, M. A. (2007). Repression of Vascular Endothelial Growth Factor Expression by the Zinc Finger Transcription Factor ZNF24. Cancer Res. 67: 8736-8741 [Abstract] [Full Text]  
  • Cleynen, I., Huysmans, C., Sasazuki, T., Shirasawa, S., Van de Ven, W., Peeters, K. (2007). Transcriptional Control of the Human High Mobility Group A1 Gene: Basal and Oncogenic Ras-Regulated Expression. Cancer Res. 67: 4620-4629 [Abstract] [Full Text]  
  • Jia, Z., Zhang, J., Wei, D., Wang, L., Yuan, P., Le, X., Li, Q., Yao, J., Xie, K. (2007). Molecular Basis of the Synergistic Antiangiogenic Activity of Bevacizumab and Mithramycin A. Cancer Res. 67: 4878-4885 [Abstract] [Full Text]  
  • Sosman, J. A., Puzanov, I., Atkins, M. B. (2007). Opportunities and Obstacles to Combination Targeted Therapy in Renal Cell Cancer. Clin. Cancer Res. 13: 764s-769s [Abstract] [Full Text]  
  • Slomiany, M. G., Rosenzweig, S. A. (2006). Hypoxia-Inducible Factor-1-Dependent and -Independent Regulation of Insulin-Like Growth Factor-1-Stimulated Vascular Endothelial Growth Factor Secretion. J. Pharmacol. Exp. Ther. 318: 666-675 [Abstract] [Full Text]  
  • Tang, N., Mack, F., Haase, V. H., Simon, M. C., Johnson, R. S. (2006). pVHL Function Is Essential for Endothelial Extracellular Matrix Deposition.. Mol. Cell. Biol. 26: 2519-2530 [Abstract] [Full Text]  
  • Nakamura, E., Abreu-e-Lima, P., Awakura, Y., Inoue, T., Kamoto, T., Ogawa, O., Kotani, H., Manabe, T., Zhang, G.-J., Kondo, K., Nose, V., Kaelin, W. G. Jr (2006). Clusterin Is a Secreted Marker for a Hypoxia-Inducible Factor-Independent Function of the von Hippel-Lindau Tumor Suppressor Protein. Am. J. Pathol. 168: 574-584 [Abstract] [Full Text]  
  • Tsuchihashi, S.-i., Ke, B., Kaldas, F., Flynn, E., Busuttil, R. W., Briscoe, D. M., Kupiec-Weglinski, J. W. (2006). Vascular Endothelial Growth Factor Antagonist Modulates Leukocyte Trafficking and Protects Mouse Livers against Ischemia/Reperfusion Injury. Am. J. Pathol. 168: 695-705 [Abstract] [Full Text]  
  • Hainsworth, J. D., Sosman, J. A., Spigel, D. R., Edwards, D. L., Baughman, C., Greco, A. (2005). Treatment of Metastatic Renal Cell Carcinoma With a Combination of Bevacizumab and Erlotinib. JCO 23: 7889-7896 [Abstract] [Full Text]  
  • Wedge, S. R., Kendrew, J., Hennequin, L. F., Valentine, P. J., Barry, S. T., Brave, S. R., Smith, N. R., James, N. H., Dukes, M., Curwen, J. O., Chester, R., Jackson, J. A., Boffey, S. J., Kilburn, L. L., Barnett, S., Richmond, G. H.P., Wadsworth, P. F., Walker, M., Bigley, A. L., Taylor, S. T., Cooper, L., Beck, S., Jurgensmeier, J. M., Ogilvie, D. J. (2005). AZD2171: A Highly Potent, Orally Bioavailable, Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor for the Treatment of Cancer. Cancer Res. 65: 4389-4400 [Abstract] [Full Text]  
  • Yuan, H., Gong, A., Young, C. Y.F. (2005). Involvement of transcription factor Sp1 in quercetin-mediated inhibitory effect on the androgen receptor in human prostate cancer cells. Carcinogenesis 26: 793-801 [Abstract] [Full Text]  
  • Pages, G., Pouyssegur, J. (2005). Transcriptional regulation of the Vascular Endothelial Growth Factor gene-a concert of activating factors. Cardiovasc Res 65: 564-573 [Abstract] [Full Text]  
  • Siemann, D. W., Bibby, M. C., Dark, G. G., Dicker, A. P., Eskens, F. A.L.M., Horsman, M. R., Marme, D., LoRusso, P. M. (2005). Differentiation and Definition of Vascular-Targeted Therapies. Clin. Cancer Res. 11: 416-420 [Abstract] [Full Text]  
  • Nakamura, K., Yamamoto, A., Kamishohara, M., Takahashi, K., Taguchi, E., Miura, T., Kubo, K., Shibuya, M., Isoe, T. (2004). KRN633: A selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase that suppresses tumor angiogenesis and growth. Molecular Cancer Therapeutics 3: 1639-1649 [Abstract] [Full Text]  
  • Kaelin, W. G. Jr. (2004). The Von Hippel-Lindau Tumor Suppressor Gene and Kidney Cancer. Clin. Cancer Res. 10: 6290S-6295S [Abstract] [Full Text]  
  • Lapchak, P. H., Melter, M., Pal, S., Flaxenburg, J. A., Geehan, C., Frank, M. H., Mukhopadhyay, D., Briscoe, D. M. (2004). CD40-induced transcriptional activation of vascular endothelial growth factor involves a 68-bp region of the promoter containing a CpG island. Am. J. Physiol. Renal Physiol. 287: F512-F520 [Abstract] [Full Text]  
  • Legros, L., Bourcier, C., Jacquel, A., Mahon, F.-X., Cassuto, J.-P., Auberger, P., Pages, G. (2004). Imatinib mesylate (STI571) decreases the vascular endothelial growth factor plasma concentration in patients with chronic myeloid leukemia. Blood 104: 495-501 [Abstract] [Full Text]  
  • Flaxenburg, J. A., Melter, M., Lapchak, P. H., Briscoe, D. M., Pal, S. (2004). The CD40-Induced Signaling Pathway in Endothelial Cells Resulting in the Overexpression of Vascular Endothelial Growth Factor Involves Ras and Phosphatidylinositol 3-Kinase. J. Immunol. 172: 7503-7509 [Abstract] [Full Text]  
  • Shie, J.-L., Wu, G., Wu, J., Liu, F.-F., Laham, R. J., Oettgen, P., Li, J. (2004). RTEF-1, a Novel Transcriptional Stimulator of Vascular Endothelial Growth Factor in Hypoxic Endothelial Cells. J. Biol. Chem. 279: 25010-25016 [Abstract] [Full Text]  
  • Akiyama, H., Tanaka, T., Itakura, H., Kanai, H., Maeno, T., Doi, H., Yamazaki, M., Takahashi, K., Kimura, Y., Kishi, S., Kurabayashi, M. (2004). Inhibition of Ocular Angiogenesis by an Adenovirus Carrying the Human von Hippel-Lindau Tumor-Suppressor Gene In Vivo. IOVS 45: 1289-1296 [Abstract] [Full Text]  
  • Sutovsky, H., Gazit, E. (2004). The von Hippel-Lindau Tumor Suppressor Protein Is a Molten Globule under Native Conditions: IMPLICATIONS FOR ITS PHYSIOLOGICAL ACTIVITIES. J. Biol. Chem. 279: 17190-17196 [Abstract] [Full Text]  
  • Wei, D., Wang, L., He, Y., Xiong, H. Q., Abbruzzese, J. L., Xie, K. (2004). Celecoxib Inhibits Vascular Endothelial Growth Factor Expression in and Reduces Angiogenesis and Metastasis of Human Pancreatic Cancer via Suppression of Sp1 Transcription Factor Activity. Cancer Res. 64: 2030-2038 [Abstract] [Full Text]  
  • Zhou, M. I., Wang, H., Foy, R. L., Ross, J. J., Cohen, H. T. (2004). Tumor Suppressor von Hippel-Lindau (VHL) Stabilization of Jade-1 Protein Occurs through Plant Homeodomains and Is VHL Mutation Dependent. Cancer Res. 64: 1278-1286 [Abstract] [Full Text]  
  • Fuchs, B., Inwards, C. Y., Janknecht, R. (2004). Vascular Endothelial Growth Factor Expression is Up-Regulated by EWS-ETS Oncoproteins and Sp1 and May Represent an Independent Predictor of Survival in Ewing's Sarcoma. Clin. Cancer Res. 10: 1344-1353 [Abstract] [Full Text]  
  • Neid, M., Datta, K., Stephan, S., Khanna, I., Pal, S., Shaw, L., White, M., Mukhopadhyay, D. (2004). Role of Insulin Receptor Substrates and Protein Kinase C-{zeta} in Vascular Permeability Factor/Vascular Endothelial Growth Factor Expression in Pancreatic Cancer Cells. J. Biol. Chem. 279: 3941-3948 [Abstract] [Full Text]  
  • Distler, J. H. W., Hagen, C., Hirth, A., Muller-Ladner, U., Lorenz, H. M., del Rosso, A., Michel, B. A., Gay, R. E., Nanagara, R., Nishioka, K., Matucci-Cerinic, M., Kalden, J. R., Gay, S., Distler, O. (2004). Bucillamine Induces the Synthesis of Vascular Endothelial Growth Factor Dose-Dependently in Systemic Sclerosis Fibroblasts via Nuclear Factor-{kappa}B and Simian Virus 40 Promoter Factor 1 Pathways. Mol. Pharmacol. 65: 389-399 [Abstract] [Full Text]  
  • Datta, K., Li, J., Bhattacharya, R., Gasparian, L., Wang, E., Mukhopadhyay, D. (2004). Protein Kinase C {zeta} Transactivates Hypoxia-Inducible Factor {alpha} by Promoting Its Association with p300 in Renal Cancer. Cancer Res. 64: 456-462 [Abstract] [Full Text]  
  • Wang, L., Wei, D., Huang, S., Peng, Z., Le, X., Wu, T. T., Yao, J., Ajani, J., Xie, K. (2003). Transcription Factor Sp1 Expression Is a Significant Predictor of Survival in Human Gastric Cancer. Clin. Cancer Res. 9: 6371-6380 [Abstract] [Full Text]  
  • Van Dort, C., Zhao, P., Parmelee, K., Capps, B., Poel, A., Listenberger, L., Kossoris, J., Wasilevich, B., Murrey, D., Clare, P., Burnatowska-Hledin, M. (2003). VACM-1, a cul-5 gene, inhibits cellular growth by a mechanism that involves MAPK and p53 signaling pathways. Am. J. Physiol. Cell Physiol. 285: C1386-C1396 [Abstract] [Full Text]  
  • Kaelin, W. G. Jr. (2003). The von Hippel-Lindau Gene, Kidney Cancer, and Oxygen Sensing. J. Am. Soc. Nephrol. 14: 2703-2711 [Abstract] [Full Text]  
  • Peng, H., He, H., Hay, J., Ruyechan, W. T. (2003). Interaction between the Varicella Zoster Virus IE62 Major Transactivator and Cellular Transcription Factor Sp1. J. Biol. Chem. 278: 38068-38075 [Abstract] [Full Text]  
  • Zheng, H., Wasylyk, C., Ayadi, A., Abecassis, J., Schalken, J. A, Rogatsch, H., Wernert, N., Maira, S.-M., Multon, M.-C., Wasylyk, B. (2003). The transcription factor Net regulates the angiogenic switch. Genes Dev. 17: 2283-2297 [Abstract] [Full Text]  
  • Schraml, P., Hergovitz, A., Hatz, F., Amin, M. B., Lim, S. D., Krek, W., Mihatsch, M. J., Moch, H. (2003). Relevance of Nuclear and Cytoplasmic von Hippel Lindau Protein Expression for Renal Carcinoma Progression. Am. J. Pathol. 163: 1013-1020 [Abstract] [Full Text]  
  • Yang, J. C., Haworth, L., Sherry, R. M., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Steinberg, S. M., Chen, H. X., Rosenberg, S. A. (2003). A Randomized Trial of Bevacizumab, an Anti-Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer. NEJM 349: 427-434 [Abstract] [Full Text]  
  • Azmi, S., Sun, H., Ozog, A., Taneja, R. (2003). mSharp-1/DEC2, a Basic Helix-Loop-Helix Protein Functions as a Transcriptional Repressor of E Box Activity and Stra13 Expression. J. Biol. Chem. 278: 20098-20109 [Abstract] [Full Text]  
  • Kuenen, B. C., Tabernero, J., Baselga, J., Cavalli, F., Pfanner, E., Conte, P. F., Seeber, S., Madhusudan, S., Deplanque, G., Huisman, H., Scigalla, P., Hoekman, K., Harris, A. L. (2003). Efficacy and Toxicity of the Angiogenesis Inhibitor SU5416 As a Single Agent in Patients with Advanced Renal Cell Carcinoma, Melanoma, and Soft Tissue Sarcoma. Clin. Cancer Res. 9: 1648-1655 [Abstract] [Full Text]  
  • Galban, S., Fan, J., Martindale, J. L., Cheadle, C., Hoffman, B., Woods, M. P., Temeles, G., Brieger, J., Decker, J., Gorospe, M. (2003). von Hippel-Lindau Protein-Mediated Repression of Tumor Necrosis Factor Alpha Translation Revealed through Use of cDNA Arrays. Mol. Cell. Biol. 23: 2316-2328 [Abstract] [Full Text]  
  • Reisinger, K., Kaufmann, R., Gille, J. (2003). Increased Sp1 phosphorylation as a mechanism of hepatocyte growth factor (HGF/SF)-induced vascular endothelial growth factor (VEGF/VPF) transcription. J. Cell Sci. 116: 225-238 [Abstract] [Full Text]  
  • Zhou, M. I., Wang, H., Ross, J. J., Kuzmin, I., Xu, C., Cohen, H. T. (2002). The von Hippel-Lindau Tumor Suppressor Stabilizes Novel Plant Homeodomain Protein Jade-1. J. Biol. Chem. 277: 39887-39898 [Abstract] [Full Text]  
  • Dollfus, H., Massin, P., Taupin, P., Nemeth, C., Amara, S., Giraud, S., Beroud, C., Dureau, P., Gaudric, A., Landais, P., Richard, S. (2002). Retinal Hemangioblastoma in von Hippel-Lindau Disease: A Clinical and Molecular Study. IOVS 43: 3067-3074 [Abstract] [Full Text]  
  • Sen, C. K., Khanna, S., Babior, B. M., Hunt, T. K., Ellison, E. C., Roy, S. (2002). Oxidant-induced Vascular Endothelial Growth Factor Expression in Human Keratinocytes and Cutaneous Wound Healing. J. Biol. Chem. 277: 33284-33290 [Abstract] [Full Text]  
  • Wedge, S. R., Ogilvie, D. J., Dukes, M., Kendrew, J., Chester, R., Jackson, J. A., Boffey, S. J., Valentine, P. J., Curwen, J. O., Musgrove, H. L., Graham, G. A., Hughes, G. D., Thomas, A. P., Stokes, E. S. E., Curry, B., Richmond, G. H. P., Wadsworth, P. F., Bigley, A. L., Hennequin, L. F. (2002). ZD6474 Inhibits Vascular Endothelial Growth Factor Signaling, Angiogenesis, and Tumor Growth following Oral Administration. Cancer Res. 62: 4645-4655 [Abstract] [Full Text]  
  • Takada, N., Sanda, T., Okamoto, H., Yang, J.-P., Asamitsu, K., Sarol, L., Kimura, G., Uranishi, H., Tetsuka, T., Okamoto, T. (2002). RelA-Associated Inhibitor Blocks Transcription of Human Immunodeficiency Virus Type 1 by Inhibiting NF-{kappa}B and Sp1 Actions. J. Virol. 76: 8019-8030 [Abstract] [Full Text]  
  • Takahashi, A., Kureishi, Y., Yang, J., Luo, Z., Guo, K., Mukhopadhyay, D., Ivashchenko, Y., Branellec, D., Walsh, K. (2002). Myogenic Akt Signaling Regulates Blood Vessel Recruitment during Myofiber Growth. Mol. Cell. Biol. 22: 4803-4814 [Abstract] [Full Text]  
  • Milanini-Mongiat, J., Pouyssegur, J., Pages, G. (2002). Identification of Two Sp1 Phosphorylation Sites for p42/p44 Mitogen-activated Protein Kinases. THEIR IMPLICATION IN VASCULAR ENDOTHELIAL GROWTH FACTOR GENE TRANSCRIPTION. J. Biol. Chem. 277: 20631-20639 [Abstract] [Full Text]  
  • Kennett, S. B., Moorefield, K. S., Horowitz, J. M. (2002). Sp3 Represses Gene Expression via the Titration of Promoter-specific Transcription Factors. J. Biol. Chem. 277: 9780-9789 [Abstract] [Full Text]  
  • Bauer, A. L., Paulding, W. R., Striet, J. B., Schnell, P. O., Czyzyk-Krzeska, M. F. (2002). Endogenous von Hippel-Lindau Tumor Suppressor Protein Regulates Catecholaminergic Phenotype in PC12 Cells. Cancer Res. 62: 1682-1687 [Abstract] [Full Text]  
  • Okuda, H., Saitoh, K., Hirai, S.-i., Iwai, K., Takaki, Y., Baba, M., Minato, N., Ohno, S., Shuin, T. (2001). The von Hippel-Lindau Tumor Suppressor Protein Mediates Ubiquitination of Activated Atypical Protein Kinase C. J. Biol. Chem. 276: 43611-43617 [Abstract] [Full Text]  
  • Pal, S., Datta, K., Mukhopadhyay, D. (2001). Central Role of p53 on Regulation of Vascular Permeability Factor/Vascular Endothelial Growth Factor (VPF/VEGF) Expression in Mammary Carcinoma. Cancer Res. 61: 6952-6957 [Abstract] [Full Text]  
  • Shi, Q., Le, X., Abbruzzese, J. L., Peng, Z., Qian, C.-N., Tang, H., Xiong, Q., Wang, B., Li, X.-C., Xie, K. (2001). Constitutive Sp1 Activity Is Essential for Differential Constitutive Expression of Vascular Endothelial Growth Factor in Human Pancreatic Adenocarcinoma. Cancer Res. 61: 4143-4154 [Abstract] [Full Text]  
  • KARUMANCHI, S. A., JIANG, L., KNEBELMANN, B., STUART-TILLEY, A. K., ALPER, S. L., SUKHATME, V. P. (2001). VHL tumor suppressor regulates Cl-/HCO3- exchange and Na+/H+ exchange activities in renal carcinoma cells. Physiol. Genomics 5: 119-128 [Abstract] [Full Text]  
  • Datta, K., Sundberg, C., Karumanchi, S. A., Mukhopadhyay, D. (2001). The 104-123 Amino Acid Sequence of the {beta}-domain of von Hippel-Lindau Gene Product Is Sufficient to Inhibit Renal Tumor Growth and Invasion. Cancer Res. 61: 1768-1775 [Abstract] [Full Text]  
  • Robinson, C., Stringer, S. (2001). The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J. Cell Sci. 114: 853-865 [Abstract]  
  • Melter, M., Reinders, M. E. J., Sho, M., Pal, S., Geehan, C., Denton, M. D., Mukhopadhyay, D., Briscoe, D. M. (2000). Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo. Blood 96: 3801-3808 [Abstract] [Full Text]  
  • Schwarte-Waldhoff, I., Volpert, O. V., Bouck, N. P., Sipos, B., Hahn, S. A., Klein-Scory, S., Luttges, J., Kloppel, G., Graeven, U., Eilert-Micus, C., Hintelmann, A., Schmiegel, W. (2000). Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis. Proc. Natl. Acad. Sci. USA 97: 9624-9629 [Abstract] [Full Text]  
  • Ellis, L. M., Gallick, G. E. (2000). Promiscuous Transcription of Vascular Endothelial Growth Factor and Survival of Tumors. JNCI J Natl Cancer Inst 92: 1030-1031 [Full Text]  
  • Zhang, L., Yu, D., Hu, M., Xiong, S., Lang, A., Ellis, L. M., Pollock, R. E. (2000). Wild-Type p53 Suppresses Angiogenesis in Human Leiomyosarcoma and Synovial Sarcoma by Transcriptional Suppression of Vascular Endothelial Growth Factor Expression. Cancer Res. 60: 3655-3661 [Abstract] [Full Text]  
  • Kishimoto, J., Ehama, R., Ge, Y., Kobayashi, T., Nishiyama, T., Detmar, M., Burgeson, R. E. (2000). In Vivo Detection of Human Vascular Endothelial Growth Factor Promoter Activity in Transgenic Mouse Skin. Am. J. Pathol. 157: 103-110 [Abstract] [Full Text]  
  • Wieczorek, E., Lin, Z., Perkins, E. B., Law, D. J., Merchant, J. L., Zehner, Z. E. (2000). The Zinc Finger Repressor, ZBP-89, Binds to the Silencer Element of the Human Vimentin Gene and Complexes with the Transcriptional Activator, Sp1. J. Biol. Chem. 275: 12879-12888 [Abstract] [Full Text]  
  • Perera, A. D., Kleymenova, E. V., Walker, C. L. (2000). Requirement for the von Hippel-Lindau Tumor Suppressor Gene for Functional Epidermal Growth Factor Receptor Blockade by Monoclonal Antibody C225 in Renal Cell Carcinoma. Clin. Cancer Res. 6: 1518-1523 [Abstract] [Full Text]  
  • Kroll, S. L., Paulding, W. R., Schnell, P. O., Barton, M. C., Conaway, J.W., Conaway, R. C., Czyzyk-Krzeska, M. F. (1999). von Hippel-Lindau Protein Induces Hypoxia-regulated Arrest of Tyrosine Hydroxylase Transcript Elongation in Pheochromocytoma Cells. J. Biol. Chem. 274: 30109-30114 [Abstract] [Full Text]  
  • Los, M., Zeamari, S., Foekens, J. A., Gebbink, M. F. B. G., Voest, E. E. (1999). Regulation of the Urokinase-type Plasminogen Activator System by the von Hippel-Lindau Tumor Suppressor Gene. Cancer Res. 59: 4440-4445 [Abstract] [Full Text]  
  • Pause, A., Peterson, B., Schaffar, G., Stearman, R., Klausner, R. D. (1999). Studying interactions of four proteins in the yeast two-hybrid system: Structural resemblance of the pVHL/elongin BC/hCUL-2 complex with the ubiquitin ligase complex SKP1/cullin/F-box protein. Proc. Natl. Acad. Sci. USA 96: 9533-9538 [Abstract] [Full Text]  
  • Gorski, D. H., Beckett, M. A., Jaskowiak, N. T., Calvin, D. P., Mauceri, H. J., Salloum, R. M., Seetharam, S., Koons, A., Hari, D. M., Kufe, D. W., Weichselbaum, R. R. (1999). Blockade of the Vascular Endothelial Growth Factor Stress Response Increases the Antitumor Effects of Ionizing Radiation. Cancer Res. 59: 3374-3378 [Abstract] [Full Text]  
  • Shih, S.-C., Mullen, A., Abrams, K., Mukhopadhyay, D., Claffey, K. P. (1999). Role of Protein Kinase C Isoforms in Phorbol Ester-induced Vascular Endothelial Growth Factor Expression in Human Glioblastoma Cells. J. Biol. Chem. 274: 15407-15414 [Abstract] [Full Text]  
  • Liakopoulos, D., Busgen, T., Brychzy, A., Jentsch, S., Pause, A. (1999). Conjugation of the ubiquitin-like protein NEDD8 to cullin-2 is linked to von Hippel-Lindau tumor suppressor function. Proc. Natl. Acad. Sci. USA 96: 5510-5515 [Abstract] [Full Text]  
  • Ananth, S., Knebelmann, B., Gruning, W., Dhanabal, M., Walz, G., Stillman, I. E., Sukhatme, V. P. (1999). Transforming Growth Factor {beta}1 Is a Target for the von Hippel-Lindau Tumor Suppressor and a Critical Growth Factor for Clear Cell Renal Carcinoma. Cancer Res. 59: 2210-2216 [Abstract] [Full Text]  
  • Chan, C.-C., Vortmeyer, A. O., Chew, E. Y., Green, W. R., Matteson, D. M., Shen, D. F., Linehan, W. M., Lubensky, I. A., Zhuang, Z. (1999). VHL Gene Deletion and Enhanced VEGF Gene Expression Detected in the Stromal Cells of Retinal Angioma. Arch Ophthalmol 117: 625-630 [Abstract] [Full Text]  
  • Gorospe, M., Egan, J. M., Zbar, B., Lerman, M., Geil, L., Kuzmin, I., Holbrook, N. J. (1999). Protective Function of von Hippel-Lindau Protein against Impaired Protein Processing in Renal Carcinoma Cells. Mol. Cell. Biol. 19: 1289-1300 [Abstract] [Full Text]  
  • Neufeld, G., Cohen, T., Gengrinovitch, S., Poltorak, Z. (1999). Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13: 9-22 [Abstract] [Full Text]  
  • Dhanabal, M., Ramchandran, R., Volk, R., Stillman, I. E., Lombardo, M., Iruela-Arispe, M. L., Simons, M., Sukhatme, V. P. (1999). Endostatin: Yeast Production, Mutants, and Antitumor Effect in Renal Cell Carcinoma. Cancer Res. 59: 189-197 [Abstract] [Full Text]  
  • Vallian, S., Chin, K.-V., Chang, K.-S. (1998). The Promyelocytic Leukemia Protein Interacts with Sp1 and Inhibits Its Transactivation of the Epidermal Growth Factor Receptor Promoter. Mol. Cell. Biol. 18: 7147-7156 [Abstract] [Full Text]  
  • Pal, S., Claffey, K. P., Cohen, H. T., Mukhopadhyay, D. (1998). Activation of Sp1-mediated Vascular Permeability Factor/Vascular Endothelial Growth Factor Transcription Requires Specific Interaction with Protein Kinase C zeta. J. Biol. Chem. 273: 26277-26280 [Abstract] [Full Text]  
  • Iliopoulos, O., Ohh, M., Kaelin, W. G. Jr. (1998). pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation. Proc. Natl. Acad. Sci. USA 95: 11661-11666 [Abstract] [Full Text]  
  • Lonergan, K. M., Iliopoulos, O., Ohh, M., Kamura, T., Conaway, R. C., Conaway, J. W., Kaelin, W. G. Jr. (1998). Regulation of Hypoxia-Inducible mRNAs by the von Hippel-Lindau Tumor Suppressor Protein Requires Binding to Complexes Containing Elongins B/C and Cul2. Mol. Cell. Biol. 18: 732-741 [Abstract] [Full Text]  
  • Pal, S., Claffey, K. P., Dvorak, H. F., Mukhopadhyay, D. (1997). The von Hippel-Lindau Gene Product Inhibits Vascular Permeability Factor/Vascular Endothelial Growth Factor Expression in Renal Cell Carcinoma by Blocking Protein Kinase C Pathways. J. Biol. Chem. 272: 27509-27512 [Abstract] [Full Text]  
  • Pages, G., Berra, E., Milanini, J., Levy, A. P., Pouyssegur, J. (2000). Stress-activated Protein Kinases (JNK and p38/HOG) Are Essential for Vascular Endothelial Growth Factor mRNA Stability. J. Biol. Chem. 275: 26484-26491 [Abstract] [Full Text]  
  • Stoner, M., Wang, F., Wormke, M., Nguyen, T., Samudio, I., Vyhlidal, C., Marme, D., Finkenzeller, G., Safe, S. (2000). Inhibition of Vascular Endothelial Growth Factor Expression in HEC1A Endometrial Cancer Cells through Interactions of Estrogen Receptor alpha and Sp3 Proteins. J. Biol. Chem. 275: 22769-22779 [Abstract] [Full Text]  
  • Pal, S., Datta, K., Khosravi-Far, R., Mukhopadhyay, D. (2001). Role of Protein Kinase Czeta in Ras-mediated Transcriptional Activation of Vascular Permeability Factor/Vascular Endothelial Growth Factor Expression. J. Biol. Chem. 276: 2395-2403 [Abstract] [Full Text]  
  • Datta, K., Nambudripad, R., Pal, S., Zhou, M., Cohen, H. T., Mukhopadhyay, D. (2000). Inhibition of Insulin-like Growth Factor-I-mediated Cell Signaling by the von Hippel-Lindau Gene Product in Renal Cancer. J. Biol. Chem. 275: 20700-20706 [Abstract] [Full Text]  
  • Quinn, T. P., Schlueter, M., Soifer, S. J., Gutierrez, J. A. (2002). Mechanotransduction in the Lung: Cyclic mechanical stretch induces VEGF and FGF-2 expression in pulmonary vascular smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 282: L897-L903 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»